[go: up one dir, main page]

FI924230L - Substituerade pyridinylamino-1h-indoler, -1h-indazoler, -2h-indazoler,-benso(b)tiofener och -1,2-bensoisotiazoler, foerfarande foer deras framstaellning och deras anvaendning som laekemedel - Google Patents

Substituerade pyridinylamino-1h-indoler, -1h-indazoler, -2h-indazoler,-benso(b)tiofener och -1,2-bensoisotiazoler, foerfarande foer deras framstaellning och deras anvaendning som laekemedel Download PDF

Info

Publication number
FI924230L
FI924230L FI924230A FI924230A FI924230L FI 924230 L FI924230 L FI 924230L FI 924230 A FI924230 A FI 924230A FI 924230 A FI924230 A FI 924230A FI 924230 L FI924230 L FI 924230L
Authority
FI
Finland
Prior art keywords
indazoler
och
deras
thiofener
indoler
Prior art date
Application number
FI924230A
Other languages
English (en)
Finnish (fi)
Other versions
FI924230A0 (fi
Inventor
Richard Charles Effland
Joseph Thomas Klein
Lawrence L Martin
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Publication of FI924230A0 publication Critical patent/FI924230A0/fi
Publication of FI924230L publication Critical patent/FI924230L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI924230A 1991-09-23 1992-09-21 Substituerade pyridinylamino-1h-indoler, -1h-indazoler, -2h-indazoler,-benso(b)tiofener och -1,2-bensoisotiazoler, foerfarande foer deras framstaellning och deras anvaendning som laekemedel FI924230L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/764,031 US5185350A (en) 1991-09-23 1991-09-23 Substituted pyridinylamino-1h-indoles,1h-indazoles,2h-indazoles, benzo (b)thiophenes and 1,2-benzisothiazoles

Publications (2)

Publication Number Publication Date
FI924230A0 FI924230A0 (fi) 1992-09-21
FI924230L true FI924230L (fi) 1993-03-24

Family

ID=25069502

Family Applications (1)

Application Number Title Priority Date Filing Date
FI924230A FI924230L (fi) 1991-09-23 1992-09-21 Substituerade pyridinylamino-1h-indoler, -1h-indazoler, -2h-indazoler,-benso(b)tiofener och -1,2-bensoisotiazoler, foerfarande foer deras framstaellning och deras anvaendning som laekemedel

Country Status (18)

Country Link
US (2) US5185350A (es)
EP (1) EP0534343B1 (es)
JP (1) JP2961023B2 (es)
KR (1) KR930006006A (es)
AT (1) ATE160346T1 (es)
AU (1) AU653263B2 (es)
CA (1) CA2078814C (es)
CZ (1) CZ290692A3 (es)
DE (1) DE69223205T2 (es)
DK (1) DK0534343T3 (es)
ES (1) ES2111025T3 (es)
FI (1) FI924230L (es)
GR (1) GR3025774T3 (es)
HU (1) HUT64055A (es)
IL (1) IL103232A0 (es)
MX (1) MX9205374A (es)
NO (1) NO923686L (es)
TW (1) TW207539B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0550507A1 (en) * 1990-09-13 1993-07-14 Beecham Group p.l.c. Indole ureas as 5 ht receptor antagonist
US5356910A (en) 1993-07-19 1994-10-18 Hoechst-Roussel Pharmaceuticals Inc. Use of N-(pyridinyl)-1H-indol-1-amines for the treatment of obsessive-compulsive disorder
EP0735821A4 (en) * 1993-12-21 1998-04-01 Lilly Co Eli METHODS FOR TREATING OR PREVENTING CONDITIONS ASSOCIATED WITH AMYLO DOGEN PEPTIDES
DE19626373A1 (de) * 1996-07-02 1998-01-08 Boehringer Ingelheim Kg Neuartige Verwendung von Wirkstoffen, welche die Funktion von nichtneuronalem Acetylcholin beeinflussen
TW200302722A (en) * 2002-02-13 2003-08-16 Astrazeneca Ab Therapeutic agents
US20050222123A1 (en) 2004-01-27 2005-10-06 North Shore-Long Island Jewish Research Institute Cholinesterase inhibitors for treating inflammation
US7592357B2 (en) * 2004-02-20 2009-09-22 Smithkline Beecham Corporation Compounds
JP4787471B2 (ja) * 2004-05-21 2011-10-05 株式会社ポッカコーポレーション 脳機能亢進剤
BRPI0511722A (pt) 2004-06-01 2008-01-08 Hoffmann La Roche 3-amino-1-arilpropilindóis como inibidores da recaptação de monoamina
BRPI0619263A2 (pt) 2005-11-30 2011-09-27 Hoffmann La Roche indóis de 3-amino-1-arilpropila e indóis aza-substituìdos, métodos para prepará-los, composição farmacêutica e uso dos referidos indóis
RU2008120141A (ru) 2005-11-30 2010-01-10 Ф. Хоффманн-Ля Рош Аг (Ch) 3-амино-2-арилпропилазаиндолы и их применения
EP2351737A1 (en) * 2005-11-30 2011-08-03 F. Hoffmann-La Roche AG 3-Amino-1-arylpropyl indoles and aza-substituted indoles
KR102534969B1 (ko) * 2021-08-20 2023-05-26 김수영 포켓 인슐레이터 및 이를 포함하는 단열체

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3852335T2 (de) * 1987-04-24 1995-05-11 Hoechst Roussel Pharma N-(Pyridinyl)-1H-indol-1-amine, Verfahren zu deren Herstellung und ihre Verwendung als Arzneimittel.
US4983615A (en) * 1989-06-28 1991-01-08 Hoechst-Roussel Pharmaceuticals Inc. Heteroarylamino- and heteroaryloxypyridinamine compounds which are useful in treating skin disorders
US4970219A (en) * 1989-06-28 1990-11-13 Hoechst-Roussel Pharmaceuticals Inc. Heteroarylamino- and heteroaryloxypyridinamine compounds which have useful utility in treating skin disorders
US5006537A (en) * 1989-08-02 1991-04-09 Hoechst-Roussel Pharmaceuticals, Inc. 1,3-dihydro-1-(pyridinylamino)-2H-indol-2-ones
US5177088A (en) * 1991-04-17 1993-01-05 Hoechst-Roussel Pharmaceuticals Incorporated Substituted 3-(pyridinylamino)-indoles

Also Published As

Publication number Publication date
HU9203023D0 (en) 1993-11-29
JP2961023B2 (ja) 1999-10-12
FI924230A0 (fi) 1992-09-21
US5328918A (en) 1994-07-12
MX9205374A (es) 1993-03-01
EP0534343B1 (en) 1997-11-19
DK0534343T3 (da) 1998-07-27
DE69223205D1 (de) 1998-01-02
GR3025774T3 (en) 1998-03-31
KR930006006A (ko) 1993-04-20
JPH061787A (ja) 1994-01-11
CZ290692A3 (en) 1993-04-14
HUT64055A (en) 1993-11-29
TW207539B (es) 1993-06-11
CA2078814C (en) 2003-09-09
IL103232A0 (en) 1993-02-21
EP0534343A1 (en) 1993-03-31
CA2078814A1 (en) 1993-03-24
NO923686D0 (no) 1992-09-22
US5185350A (en) 1993-02-09
DE69223205T2 (de) 1998-05-14
AU653263B2 (en) 1994-09-22
ATE160346T1 (de) 1997-12-15
NO923686L (no) 1993-03-24
ES2111025T3 (es) 1998-03-01
AU2529792A (en) 1993-03-25

Similar Documents

Publication Publication Date Title
FI925735L (fi) Polymerer och oligomerer av gallsyraderivat, foerfarande foer deras framstaellning och deras anvaendning som laekemedel
FI915387L (fi) Tuggummi, som avger smak under en foerlaengd tidsperiod och som innehaoller omaettade, renade monoglycerider.
FI932659L (fi) Gallsyraderivat, foerfaranden foer deras framstaellning och anvaendning avdessa foereningar som laekemedel
FI911588L (fi) En paoses staengningskonstruktion, daer en enda loestagbar tillslutare fungerar baode som en primaer och en sekundaer tillslutare.
FI921952A0 (fi) Foerfarande foer framstaellning av dialkylenpiperidinofoereningar och enantiomerer daerav anvaendbara som laekemedel.
FI931250L (fi) Sulfonamido- och sulfonamidokarbonyl-pyridin-2-karboxylsyraamider och deras pyridin-n-oxider, foerfarande foer deras framstaellning och deras anvaendning som laekemedel
FI922454A0 (fi) Peptider och antikroppar som inhiberar integrinligandbindning.
FI923558A (fi) Tetrahydroindazol-, tetrahydrocyklopentapyrazol- och hexahydrocykloheptapyrazolfoereningar och deras anvaendning som inhibitorer av hmg-coa-reduktas
FI931336L (fi) Laekemedel som innehaoller polyhydroximetylenderivat, foerfarande foer deras framstaellning och bruk
FI921073A0 (fi) Kompositioner, vilka aer laempliga som bindemedel och skyddsbelaeggningar foer tryckfaerger.
FI902248A0 (fi) N-heteroaryl-4-kinolinaminer, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
FI923055L (fi) Papper foer anvaendning som fodringspapper foer gipskartong, och foerfaranden foer dess framstaellning
FI923185A0 (fi) Foerfarande och anordning foer framstaellning av fogloesa band- och traodoeglor och deras anvaendning som kapverktyg i band- och traodsaogar.
FI911512L (fi) Oeverbasiska calixarater, foerfarande foer deras framstaellning, kompositioner innehaollande desamma och deras anvaendning som tillsatsaemnen i smoerjaemnen.
FI913201L (fi) Ymppolysackarider, deras framstaellningsfoerfarande och deras anvaendning som sekvesteringsagenter.
FI920342L (fi) Komplex som innehaoller koaguleringsfaktor ix och foerfarande foer framstaellning daerav.
FI924230L (fi) Substituerade pyridinylamino-1h-indoler, -1h-indazoler, -2h-indazoler,-benso(b)tiofener och -1,2-bensoisotiazoler, foerfarande foer deras framstaellning och deras anvaendning som laekemedel
FI921974A0 (fi) Lageranlaeggning och undervattens- drivkraftsenhet som innehaoller den.
FI920192L (fi) Substituerade 1,2,3,4-tetrahydro -cyklopent/b/indoler, 1,2,3,3a,4,8a-hexahydrocyklopent/b/indoler och motsvarande foereningar, mellanprodukter och foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
FI891411A0 (fi) Neopentylesterderivat, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
FI921596A0 (fi) Tetron- och tietetronsyraderivat och fosfolifas a2 som inhibitorer.
FI903214A0 (fi) Naftyl- och naftyloxi- pyrimidiner och dessa beroerande foereningar, foerfarande foer deras framstaellning och deras anvaendning som dermatologiska laekemedel.
FI913138A0 (fi) Foerfarande foer framstaellning av b -laktamer som innehaoller aminotiazol(iminooxiaettiksyra) aettiksyrasidokedjor och mellanprodukter daerav.
FI914556A0 (fi) 4- eller 5-substituerade pyridiner-2-karboxylsyror, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
FI905689A0 (fi) 3-aminopyrroler, foerfaranden foer deras framstaellning, och deras anvaendning som laekemedel.